China Health Holding Announces Scientific Advisory Board.BEIJING -- China Health Holding (NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). OTCBB OTCBB See OTC Bulletin Board (OTCBB). : CHHH), a developer, marketer and manufacturer of natural herbal supplement products based on traditional Chinese Medicine Traditional Chinese Medicine Definition Traditional Chinese medicine (TCM) is an ancient and still very vital holistic system of health and healing, based on the notion of harmony and balance, and employing the ideas of moderation and prevention. , announced today the formation of its Scientific Advisory Board. The Company has attracted knowledgeable, experienced and successful directors, advisors and management to guide its development process. The Company is currently in discussions with and actively recruiting world class scientific and pharmaceutical and TCM (1) (Trellis-Coded Modulation/Viterbi Decoding) A technique that adds forward error correction to a modulation scheme by adding an additional bit to each baud. TCM is used with QAM modulation, for example. (traditional Chinese medicine) specialists, as well as prominent, highly experienced business advisors to join the Company's scientific advisor board and board of directors and world-class management team. CHHH OTCBB Scientific Advisor Board : Professor Yu, Edward (X.F.): Chief TCM Advisor Instrumental in the development of numerous natural products for China Health Holding, Inc., Professor Yu was elected to the Board and appointed Vice President in 2004. Past President and Director of Beijing's Taoist Tantric tan·tra n. Any of a comparatively recent class of Hindu or Buddhist religious literature written in Sanskrit and concerned with powerful ritual acts of body, speech, and mind. & Toltec Research & Development Centre, he is currently a Research Scientific Consultant at the city's Central TSM TSM Tivoli Storage Manager TSM Transportation System Management TSM Taiwan Semiconductor Manufacturing (stock symbol) TSM Taiwan Semiconductor Manufacturing Co. Ltd. Research & Development Institute. Presently a professor in the Department of Philosophy, Professor Yu teaches Taoism, Taoist Medicine and Indian classical philosophy and religion at Beijing's University of CCCP CCCP transliteration of Cyrillic USSR, equivalent to Union of Soviet Socialist Republics in English CCCP Combined Community Codec Pack CCCP Central Committee of the Communist Party CCCP Caltech Core-Collapse Project . Dr. Ma, Yua-Chun : Chief Scientific Advisor Dr. Ma, the President/CEO of Canadian Phytopharmaceutical, specializes in Research & development and manufacturing of botanical and natural pharmaceutical products. He received an M.Sc. at HuBei University, PR China and Ph.D. in Pharmaceutical Science at the University of Portsmouth Portsmouth seems better placed than most Post-1992 universities to deal with the surge of applications encouraged by the government's target that 50% of those under-35 should experience Higher Education at some point in their life. , England. He served as senior consultant for Health Canada and Agriculture Canada and also for the National Research Council of Canada The National Research Council Canada (NRC) is Canada's leading organization for scientific research and development. History NRC was established in 1916, mainly to advise the government. Then, in the early 1930s, laboratories were built in Ottawa. in R &D on standardization for Natural Health Products in BC Canada. Professor Fan, Zheng-lun : Co-Chief TCM Advisor In 1982, Professor Zheng-Lun Fan acquired his MSC (1) (MSC.Software Corporation, Santa Ana, CA, www.mscsoftware.com) Founded in 1963 by Richard H. MacNeal and Robert G. Schwendler, MSC is the world's largest provider of mechanical computer aided engineering (MCAE) strategies, simulation software and services. in Liao-Ning College of Traditional Chinese Medicine. During the past five years, he has been a Research Fellow at Cui Yue-li Research Center of Traditional Chinese Medicine. Professor Fan also is a MSC, Professor, Chief Physician Research Fellow at Cui Yue-li Research Center of Traditional Chinese Medicine, Beijing, P.R. China. Prof. Fan is an expert of Chinese medicine at the national level in P. R. China and he has practiced Chinese medicine for more than 40 years. About China Health Holding, Inc. China Health Holding, Inc., incorporated in 2002, is a developer, marketer and manufacturer of Innovative Enhanced Traditional Chinese Medicinal herbal supplement product lines. The Company's product lines also include dietary food supplements that are helpful in strengthening the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. and cardio-cerebral vascular function as well as promoting overall physical and mental health. The Company plans to introduce a line of natural skin care and cosmetic products as well as to develop new products based on its knowledge of traditional Chinese medical practice. Please visit China Health Holding, Inc.'s website www.chinahealthholding.com for Company Profile details. Safe Harbor To the extent that statements in the press releases are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, All forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all the Company's press releases to reflect events or circumstances after the date hereof. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion